Management of Preterm Infants with Intracardiac Thrombi: Use of Thrombolytic Agents

Author： Rimensberger P.C.   Humbert J.R.   Beghetti M.  

Publisher： Adis International

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.3, Iss.12, 2001-01, pp. : 883-898

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bronchopulmonary Dysplasia in Preterm Infants: Pathophysiology and Management Strategies

By Carl T. D’Angio   William M. Maniscalco  

Pediatric Drugs, Vol. 6, Iss. 5, 2004-01 ,pp. : 303-330

Adis International

Access to resources Recommend Favorite

The Role of Antiplatelet Agents in the Management of Patients Receiving Intracardiac Closure Devices

By  

Current Pharmaceutical Design, Vol. 12, Iss. 10, 2006-04 ,pp. : 1287-1291

Bentham Science Publishers

Access to resources Recommend Favorite

Heparin: Thrombocytopenia and intracardiac thrombi following coronary bypass: case report

By  

Reactions Weekly, Vol. 1, Iss. 1250, 2009-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Current Perspectives on the Prevention and Management of Chronic Lung Disease in Preterm Infants

By Shah P.S.  

Pediatric Drugs, Vol. 5, Iss. 7, 2003-01 ,pp. : 463-480

Adis International

Access to resources Recommend Favorite

Management of Bronchopulmonary Dysplasia in Infants: Guidelines for Corticosteroid Use

By Grier David G.   Halliday Henry L.  

Drugs, Vol. 65, Iss. 1, 2005-01 ,pp. : 15-29

Adis International

Access to resources Recommend Favorite